Skip to main content
News

Ellume / QIAGEN Partnership is Making Tuberculosis Testing More Accessible · BioBuzz

By February 21, 2022No Comments
NewImage

NewImage

While COVID has most certainly been top-of-mind for companies working to combat infectious disease, we must not forget the other microbes out there that are still cause for concern. 

Tuberculosis (TB) is a prime example. Most have heard of this disease, but probably in the context of their history classes. You might be surprised to hear, then, that tuberculosis caused an estimated 1.5 million deaths in 2020, making it second only to COVID as the leading cause of death due to an infectious agent.

Image: https://biobuzz.io

{iframe}https://biobuzz.io/ellume-qiagen-partnership-is-making-tuberculosis-testing-more-accessible/{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.